CIK: 0001388551
Total reported value
$4.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XERS | Xeris Biopharma Holdings INC | Stock-Other | 41.06% | — | -60.59% | |
| 2 | RZLT | Rezolute INC | Stock-Other | 38.85% | — | — | |
| 3 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 9.94% | — | -1.53% | |
| 4 | BRK-B | Berkshire Hathaway Inc-cl B | Stock-Other | 3.09% | +0.32% | -1.56% | |
| 5 | GLD | Spdr Gold Shares | ETF-Commodities | 1.70% | +17.00% | — | |
| 6 | BRD1EUR | Mind Medicine Mindmed INC | Stock-Other | 1.43% | -4.91% | EXIT | |
| 7 | BCAX | Bicara Therapeutics INC | Stock-Other | 1.15% | — | — | |
| 8 | LXEO | Lexeo Therapeutics INC | Stock-Other | 0.71% | -1.25% | — | |
| 9 | KYTX | Kyverna Therapeutics INC | Stock-Other | 0.52% | -0.09% | — | |
| 10 | CMPX | Compass Therapeutics INC | Stock-Other | 0.38% | -3.70% | EXIT | |
| 11 | CRDF | Cardiff Oncology INC | Stock-Other | 0.35% | — | — | |
| 12 | IKT | Inhibikase Therapeutics INC | Stock-Other | 0.32% | -0.17% | — | |
| 13 | GLYCEUR | Glycomimetics INC | Stock-Other | 0.31% | — | — | |
| 14 | CNTX | Context Therapeutics INC | Stock-Other | 0.12% | -0.63% | EXIT | |
| 15 | TORCEUR | Adicet Bio INC | Stock-Other | 0.10% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RZLT | Rezolute INC | +12.4% | — | Unchanged |
| 2 | SPY | Ss Spdr S&p 500 ETF Trust-us | +3.1% | -1.53% | Trim |
| 3 | GLD | Spdr Gold Shares | +1.7% | NEW | New buy |
| 4 | BRK-B | Berkshire Hathaway Inc-cl B | +0.9% | -1.56% | Trim |
| 5 | BRD1EUR | Mind Medicine Mindmed INC | +0.6% | — | Unchanged |
| 6 | CRDF | Cardiff Oncology INC | +0.4% | NEW | New buy |
| 7 | IKT | Inhibikase Therapeutics INC | +0.3% | NEW | New buy |
| 8 | GLYCEUR | Glycomimetics INC | +0.3% | NEW | New buy |
| 9 | KYTX | Kyverna Therapeutics INC | +0.1% | — | Unchanged |
| 10 | CMPX | Compass Therapeutics INC | +0.1% | — | Unchanged |
| 11 | LXEO | Lexeo Therapeutics INC | 0% | — | Unchanged |
| 12 | BCAX | Bicara Therapeutics INC | — | — | Unchanged |
| 13 | TORCEUR | Adicet Bio INC | — | — | Unchanged |
| 14 | CNTX | Context Therapeutics INC | 0% | — | Unchanged |
| 15 | ABVX | Abivax Sa-adr | -0.5% | EXIT | Sold out |
| 16 | XERS | Xeris Biopharma Holdings INC | -19.3% | -60.59% | Trim |